insights

Key Takeaways from Recent Regulatory Guidance

General Counsel, outside counsel, compliance executives, representatives of regulatory bodies, and forensic practitioners discussed an array of issues at the 19th Annual FCPA & Anti-Corruption for the Life Sciences Industry conference in New York City from May 9th to 10th 2024. The following highlights some of the topics discussed. Ephemeral Messaging and Off-Channel Communications Ephemeral…

Read post

Resolution Economics to Participate in Live Webinar “AI Bias Audits and Emerging Risks When Using AI for Hiring & Employment”

Resolution Economics’ Paul White, Ph.D. and Gurkan Ay, Ph.D. will join Davis Wright Tremaine attorneys K.C. Halm (Co-Chair, DWT’s AI Team) and Matt Jedreski (Counsel, DWT’s Employment Group) on Tuesday, May 21, 2024, 2:00–3:00 pm ET, to examine the legal risks, challenges, and opportunities presented by the adoption of AI/ML in the context of hiring…

Read post

Unpacking DOJ Criminal Division’s New Pilot Program on Voluntary Self-Disclosure for Individuals  

The DOJ’s Criminal Division recently initiated a new self-disclosure pilot program (“Pilot Program”). As Deputy Attorney General Lisa Monaco has explained, under the Pilot Program: “[I]n exchange for self-disclosing, fully cooperating with authorities, and paying any applicable victim compensation, restitution, forfeiture, or disgorgement, including returning any ill-gotten gains, the Criminal Division will enter into a non-prosecution…

Read post

Resolution Economics to participate in the 2024 Littler Executive Employer Conference

Resolution Economics’ Victoria A. Lipnic, Esq., will join Littler Shareholders Barry Hartstein, Esq., and James Paretti, Esq., as well as EEOC commissioner Keith Sonderling, on May 10th, 2024, to present “An Insider’s View of the EEOC: Recent and Current Strategies, Litigation, Settlements, and What’s on the Horizon” at the 2024 Littler Executive Employer Conference. Use…

Read post

Key Takeaways from 2024 Annual Pharma Congress

General Counsel, outside counsel, compliance executives, representatives of regulatory bodies and forensic practitioners met to discuss an array of issues at the 2024 Pharmaceutical Compliance Congress. The following highlights a few key topics.   Top Considerations for Compliance Professionals Managing the continued expansion of the compliance department’s scope and ensuring the department is appropriately resourced…

Read post